Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366606412> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W4366606412 endingPage "B27" @default.
- W4366606412 startingPage "B25" @default.
- W4366606412 abstract "Cardiotoxicity is a relatively frequent and potentially serious side effect of anticancer treatments, particularly anthracyclines and trastuzumab, widely used in the treatment of breast cancer. The increase in cancer survivors has generated a growing interest in the prevention of cardiotoxicity. Although early studies suggested an overall benefit on cardiac function with the use of ACE inhibitors (ACEIs) and beta blockers (BBs), more recent randomized trials have demonstrated little or no effect of pharmacological interventions. Even the various meta-analyses conducted in this area have provided weak results in favour of cardioprotective therapies for which the benefit would not always justify the risk of developing side effects. Given the incompleteness of the evidence, there is no clear consensus on which patients should initiate cardioprotective therapy. As recommended in the new guidelines of the European Society of Cardiology, risk stratification before treatment is crucial to identify high-risk patients who would benefit most from the use of cardioprotective therapy. Randomized trials are currently underway to evaluate other therapeutic strategies such as sacubitril/valsartan, and the possibility of using gliflozins in the future cannot be excluded. However, rigorous control and treatment of risk factors remain the primary focus in the management of these patients." @default.
- W4366606412 created "2023-04-23" @default.
- W4366606412 creator A5022586287 @default.
- W4366606412 creator A5036721273 @default.
- W4366606412 creator A5048622985 @default.
- W4366606412 creator A5052117173 @default.
- W4366606412 creator A5055833762 @default.
- W4366606412 creator A5082825994 @default.
- W4366606412 date "2023-04-01" @default.
- W4366606412 modified "2023-10-02" @default.
- W4366606412 title "Cardiac toxicity of chemotherapy for breast cancer: do angiotensin-converting enzyme inhibitors and beta blockers protect?" @default.
- W4366606412 cites W2109775164 @default.
- W4366606412 cites W2147646179 @default.
- W4366606412 cites W2298838354 @default.
- W4366606412 cites W2470078220 @default.
- W4366606412 cites W2800400752 @default.
- W4366606412 cites W2948656647 @default.
- W4366606412 cites W2976359791 @default.
- W4366606412 cites W2980271263 @default.
- W4366606412 cites W3002783226 @default.
- W4366606412 cites W3151108354 @default.
- W4366606412 cites W3163516107 @default.
- W4366606412 cites W3194258825 @default.
- W4366606412 cites W4200188794 @default.
- W4366606412 cites W4200211048 @default.
- W4366606412 cites W4220804710 @default.
- W4366606412 cites W4293217929 @default.
- W4366606412 doi "https://doi.org/10.1093/eurheartjsupp/suad062" @default.
- W4366606412 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37091667" @default.
- W4366606412 hasPublicationYear "2023" @default.
- W4366606412 type Work @default.
- W4366606412 citedByCount "0" @default.
- W4366606412 crossrefType "journal-article" @default.
- W4366606412 hasAuthorship W4366606412A5022586287 @default.
- W4366606412 hasAuthorship W4366606412A5036721273 @default.
- W4366606412 hasAuthorship W4366606412A5048622985 @default.
- W4366606412 hasAuthorship W4366606412A5052117173 @default.
- W4366606412 hasAuthorship W4366606412A5055833762 @default.
- W4366606412 hasAuthorship W4366606412A5082825994 @default.
- W4366606412 hasBestOaLocation W43666064121 @default.
- W4366606412 hasConcept C121608353 @default.
- W4366606412 hasConcept C126322002 @default.
- W4366606412 hasConcept C143998085 @default.
- W4366606412 hasConcept C168563851 @default.
- W4366606412 hasConcept C177713679 @default.
- W4366606412 hasConcept C2776694085 @default.
- W4366606412 hasConcept C2778233292 @default.
- W4366606412 hasConcept C2779786085 @default.
- W4366606412 hasConcept C530470458 @default.
- W4366606412 hasConcept C71924100 @default.
- W4366606412 hasConcept C98274493 @default.
- W4366606412 hasConceptScore W4366606412C121608353 @default.
- W4366606412 hasConceptScore W4366606412C126322002 @default.
- W4366606412 hasConceptScore W4366606412C143998085 @default.
- W4366606412 hasConceptScore W4366606412C168563851 @default.
- W4366606412 hasConceptScore W4366606412C177713679 @default.
- W4366606412 hasConceptScore W4366606412C2776694085 @default.
- W4366606412 hasConceptScore W4366606412C2778233292 @default.
- W4366606412 hasConceptScore W4366606412C2779786085 @default.
- W4366606412 hasConceptScore W4366606412C530470458 @default.
- W4366606412 hasConceptScore W4366606412C71924100 @default.
- W4366606412 hasConceptScore W4366606412C98274493 @default.
- W4366606412 hasIssue "Supplement_B" @default.
- W4366606412 hasLocation W43666064121 @default.
- W4366606412 hasLocation W43666064122 @default.
- W4366606412 hasOpenAccess W4366606412 @default.
- W4366606412 hasPrimaryLocation W43666064121 @default.
- W4366606412 hasRelatedWork W2029518877 @default.
- W4366606412 hasRelatedWork W2084938131 @default.
- W4366606412 hasRelatedWork W2092771806 @default.
- W4366606412 hasRelatedWork W2143625559 @default.
- W4366606412 hasRelatedWork W2327259730 @default.
- W4366606412 hasRelatedWork W2367874297 @default.
- W4366606412 hasRelatedWork W2918970421 @default.
- W4366606412 hasRelatedWork W2969515167 @default.
- W4366606412 hasRelatedWork W4225390758 @default.
- W4366606412 hasRelatedWork W2342209702 @default.
- W4366606412 hasVolume "25" @default.
- W4366606412 isParatext "false" @default.
- W4366606412 isRetracted "false" @default.
- W4366606412 workType "article" @default.